v3.26.1
SHAREHOLDERS' EQUITY (Details) - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended
Mar. 13, 2026
Jan. 20, 2026
Feb. 24, 2025
Feb. 18, 2025
Feb. 05, 2025
Jan. 28, 2025
Mar. 25, 2026
Jan. 22, 2026
Oct. 31, 2025
Nov. 30, 2024
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Mar. 11, 2026
Mar. 02, 2026
Jan. 14, 2026
Dec. 31, 2025
Sep. 05, 2025
Sep. 30, 2024
Mar. 31, 2022
Stockholders’ Equity [Line Items]                                              
Common stock shares authorized                     150,000,000       150,000,000         150,000,000      
Common stock par value (in dollars per share)                     $ 0.0001       $ 0.0001         $ 0.0001      
Common stock, shares issued                     2,659,288       2,659,288         1,163,142      
Common stock outstanding   1,359,091 1,472,891 7,364,554             2,659,288       2,659,288       5,436,441 1,163,142      
Reverse stock split   1:4 1:5 1:5         Following stockholder approval in October 2025, the Company effected an additional reverse stock split at a ratio of 1:4 (the “1:4 Reverse Stock Split” and together with the 1:5 Reverse Stock Split, the “Reverse Stock Splits”). Following stockholder approval in November 2024, the Company effected a reverse stock split at a ratio of 1:5, which was effective as of February 24, 2025 (the “1:5 Reverse Stock Split”).   1:4   1:5                  
Exercise of warrants                                           96,300  
Dividends percentage                             6.00%                
Dividends preferred stock                             $ 1,464,691                
Proceeds from Exercise of Pre-Funded Warrants                             $ 1,926              
Net Proceeds from February 2025 Offering                             $ 908,627              
Warrants, each warrant to purchase one share of Common Stock                                              
Stockholders’ Equity [Line Items]                                              
Number of Warrants, Exercised                     (96,300)                  
Number of warrants granted                     186,807                  
Number of warrants exercisable                     1,896,928   531,784   1,896,928 531,784              
Weighted average exercise price (in dollars per share)                       $ 0.02                  
Pre-Funded Warrant [Member]                                              
Stockholders’ Equity [Line Items]                                              
Exercise of warrants                         0     0              
Number of Warrants, Exercised                             0 96,300              
Proceeds from Exercise of Pre-Funded Warrants                             $ 0 $ 1,926              
Issuance of common stock upon exercise of Pre-Funded Warrants (in shares)                             0 96,300              
2025 ATM Agreement [Member]                                              
Stockholders’ Equity [Line Items]                                              
Sale of stock price per share (in dollars per share)               $ 2.07                              
ATM Offering               418,602                              
Proceeds from common stock sales agreement net               $ 834,705             $ 3,800,000                
2026 ATM Offering [Member]                                              
Stockholders’ Equity [Line Items]                                              
Sale of stock price per share (in dollars per share)             $ 2.49                                
ATM Offering             1,055,106                                
Proceeds from common stock sales agreement net             $ 2,535,047                                
Common stock aggregate gross sales proceeds authorized                                   $ 1,308,000          
Increased common stock aggregate gross sales proceeds authorized                                 $ 981,000            
January 2025 Offering [Member]                                              
Stockholders’ Equity [Line Items]                                              
Net proceeds from Private Placement           $ 804,346                                  
Issuance of common stock and warrants pursuant to January 2025 Offering, net of offering costs paid at closing and deferred offering costs (Note 6) (in Shares)           51,079                                  
January 2025 Offering [Member] | January 2025 Warrants [Member]                                              
Stockholders’ Equity [Line Items]                                              
Exercise of warrants           102,158                                  
Exercise price of warrants (in dollars per share)           $ 15.42                                  
Class of Warrant or Rights Expiry Term           24 months                                  
January 2025 Offering [Member] | January 2025 Agent Warrants [Member]                                              
Stockholders’ Equity [Line Items]                                              
Exercise of warrants           3,833                                  
Exercise price of warrants (in dollars per share)           $ 25.53                                  
Class of Warrant or Rights Expiry Term           24 months                                  
February 2025 Offering [Member]                                              
Stockholders’ Equity [Line Items]                                              
Issuance of common stock and warrants pursuant to January 2025 Offering, net of offering costs paid at closing and deferred offering costs (Note 6) (in Shares)         75,176                                    
Net Proceeds from February 2025 Offering         $ 908,627                                    
February 2025 Offering [Member] | January 2025 Warrants [Member]                                              
Stockholders’ Equity [Line Items]                                              
Date from which warrants exercisable           Jan. 30, 2025                                  
February 2025 Offering [Member] | February 2025 Warrants [Member]                                              
Stockholders’ Equity [Line Items]                                              
Exercise of warrants         75,176                                    
Exercise price of warrants (in dollars per share)         $ 11.8                                    
Class of Warrant or Rights Expiry Term         24 months                                    
February 2025 Offering [Member] | February 2025 Agent Warrants [Member]                                              
Stockholders’ Equity [Line Items]                                              
Exercise of warrants         5,640                                    
Exercise price of warrants (in dollars per share)         $ 17.88                                    
Class of Warrant or Rights Expiry Term         24 months                                    
Common Stock, par value $0.0001 per share                                              
Stockholders’ Equity [Line Items]                                              
Issuance of common stock upon exercise of Pre-Funded Warrants (in shares) [1]                           96,300                  
Issuance of common stock and warrants pursuant to January 2025 Offering, net of offering costs paid at closing and deferred offering costs (Note 6) (in Shares) [1]                           51,079                  
Common Stock, par value $0.0001 per share | January 2025 Offering [Member]                                              
Stockholders’ Equity [Line Items]                                              
Sale of stock price per share (in dollars per share)           $ 20.42                                  
Common Stock, par value $0.0001 per share | February 2025 Offering [Member]                                              
Stockholders’ Equity [Line Items]                                              
Sale of stock price per share (in dollars per share)         $ 14.3                                    
H C Wainwright And Co LLC [Member] | 2025 ATM Agreement [Member]                                              
Stockholders’ Equity [Line Items]                                              
Common stock aggregate gross sales proceeds authorized                                         $ 1,397,532    
Sales agent commission percentage                                         3.00%    
H C Wainwright And Co LLC [Member] | 2026 ATM Offering [Member]                                              
Stockholders’ Equity [Line Items]                                              
Sales agent commission percentage                                   3.00%          
H C Wainwright And Co LLC [Member] | March 2026 At-the-Market Agreement [Member]                                              
Stockholders’ Equity [Line Items]                                              
Common stock aggregate gross sales proceeds authorized increase $ 565,000                                            
Series A Preferred Stock [Member]                                              
Stockholders’ Equity [Line Items]                                              
Preferred stock converted shares (in Dollars per share)                     $ 1,200       $ 1,200                
Preferred stock shares authorized                     1,000,000       1,000,000         1,000,000      
Preferred stock shares, par value (in dollars per share)                     $ 0.0001       $ 0.0001         $ 0.0001      
Preferred stock shares issued                     76,480       76,480                
Preferred stock shares outstanding                     76,480       76,480         76,480      
Dividends percentage                             19.90%                
Dividends preferred stock                     $ 134,307   $ 126,705   $ 259,619 $ 244,863              
Common stock conversion price per share (in dollars per share)                             $ 100                
Series A Non-Voting Convertible Preferred Stock [Member]                                              
Stockholders’ Equity [Line Items]                                              
Designated shares                     80,965       80,965               80,965
[1] Prior periods presented have been adjusted to reflect the 1:4 reverse stock split on January 20, 2026.